Log in or Sign up for Free to view tailored content for your specialty!
Cirrhosis/Liver Failure News
Alcohol-use disorder: Unmasked or exacerbated by the pandemic?
The COVID-19 pandemic stripped away layers of sugarcoating in our society — it exposed weak points across aspects of American life, stretched resources in public health and highlighted a deficit in recognition and access to mental health care and addiction medicine.
Cirrhotic COVID-19 survivors show poor short-term outcomes, no differences long-term
SAN DIEGO — Patients with cirrhosis who survived COVID-19 may not have worsening of underlying disease or death in the long-term compared with cirrhotic patients who never acquired COVID-19, noted data from Digestive Disease Week 2022.
Log in or Sign up for Free to view tailored content for your specialty!
Liver fat percentage does not alter risk for CV events
SAN DIEGO — Liver fat content is not associated with risk for any cardiovascular event, according to data from the Dallas Heart Study presented at the AACE Annual Scientific and Clinical Conference.
PPI use should be limited to appropriate indications, lowest effective dose in cirrhosis
Although proton pump inhibitors were linked with an increased risk for infection and decompensation in patients with cirrhosis, they may still be of benefit in those with prior gastrointestinal bleeding, according to published data.
Q&A: Drinking pickle juice may reduce muscle cramp severity in patients with cirrhosis
Pickle juice consumed at the onset of muscle cramps improved severity but did not prevent future cramps in patients with cirrhosis, according to research published in the American Journal of Gastroenterology.
VIDEO: New interventions may soon treat alcohol-related hepatitis, expert says
In this Healio video exclusive, Steven L. Flamm, MD, chief of the hepatology program at Northwestern Feinberg School of Medicine, discusses the rise in alcohol-related hepatitis during COVID-19, as well as promising new treatment options.
Heavy alcohol use increases liver impairment, risk for HCC in hepatitis-induced cirrhosis
Among patients with hepatitis-induced cirrhosis, heavy alcohol consumption increased liver function impairment and hepatocellular carcinoma prevalence, according to research.
Long, irregular menstrual cycles may increase NAFLD risk for premenopausal women
Premenopausal women with long or irregular menstrual cycles have a higher risk for prevalent and incident nonalcoholic fatty liver disease compared with women with normal cycles, according to study findings.
Expert: Patients with cirrhosis have a ‘sufficiently high risk’ for liver cancer
Screening for hepatocellular carcinoma is critical in high-risk patients, according to a presentation at GUILD conference 2022.
Male sex, low free T4 risk factors for liver dysfunction with radioactive iodine therapy
Among adults who undergo radioactive iodine therapy for differentiated thyroid cancer, risk for hepatic dysfunction is elevated for men and all with low free thyroxine or high triglycerides, according to study data.
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read
-
Headline News
A potential new paradigm for treating acute migraine: Timolol nasal spray
November 15, 20245 min read -
Headline News
AI-enabled video of skin on face, hands may detect high blood pressure, diabetes
November 15, 20242 min read -
Headline News
‘Troubling’ data show lack of awareness about lung cancer screening
November 15, 20242 min read